BRPI1009090A2 - composto, pró-droga, medicamento, métodos, e, uso do composto - Google Patents
composto, pró-droga, medicamento, métodos, e, uso do compostoInfo
- Publication number
- BRPI1009090A2 BRPI1009090A2 BRPI1009090A BRPI1009090A BRPI1009090A2 BR PI1009090 A2 BRPI1009090 A2 BR PI1009090A2 BR PI1009090 A BRPI1009090 A BR PI1009090A BR PI1009090 A BRPI1009090 A BR PI1009090A BR PI1009090 A2 BRPI1009090 A2 BR PI1009090A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- prodrug
- medicine
- methods
- compound use
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 239000003814 drug Substances 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009077078 | 2009-03-26 | ||
| PCT/JP2010/055257 WO2010110378A1 (ja) | 2009-03-26 | 2010-03-25 | ピラゾール化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1009090A2 true BRPI1009090A2 (pt) | 2016-03-01 |
Family
ID=42781069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1009090A BRPI1009090A2 (pt) | 2009-03-26 | 2010-03-25 | composto, pró-droga, medicamento, métodos, e, uso do composto |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8895588B2 (pt) |
| EP (1) | EP2412713B1 (pt) |
| JP (1) | JP5552481B2 (pt) |
| KR (1) | KR101656906B1 (pt) |
| CN (1) | CN102448953B (pt) |
| AU (1) | AU2010228220B2 (pt) |
| BR (1) | BRPI1009090A2 (pt) |
| CA (1) | CA2756086A1 (pt) |
| CL (1) | CL2011002351A1 (pt) |
| CO (1) | CO6460700A2 (pt) |
| CR (1) | CR20110533A (pt) |
| DO (1) | DOP2011000296A (pt) |
| EA (1) | EA019853B1 (pt) |
| EC (1) | ECSP11011419A (pt) |
| GE (1) | GEP20156222B (pt) |
| IL (1) | IL215235A (pt) |
| MA (1) | MA33214B1 (pt) |
| MX (1) | MX2011009943A (pt) |
| NZ (1) | NZ595890A (pt) |
| PE (1) | PE20120618A1 (pt) |
| SG (1) | SG174476A1 (pt) |
| TN (1) | TN2011000474A1 (pt) |
| UA (1) | UA107457C2 (pt) |
| WO (1) | WO2010110378A1 (pt) |
| ZA (1) | ZA201107435B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR091567A1 (es) | 2012-06-27 | 2015-02-11 | Takeda Pharmaceutical | Preparacion liquida, metodo, kit de inyeccion |
| EP2906041A4 (en) | 2012-09-27 | 2016-10-26 | Aratana Therapeutics Inc | COMPOSITIONS AND METHODS FOR USE IN A CAPACITY CONNECTOR |
| CA2974012C (en) | 2015-01-28 | 2020-08-18 | Aratana Therapeutics, Inc. | Compositions and methods for chronic use of a weight-gaining compound |
| CN105067814A (zh) * | 2015-07-24 | 2015-11-18 | 中国科学院成都生物研究所 | 解旋酶水解atp活性测定方法 |
| AU2021293694B2 (en) * | 2020-06-17 | 2023-12-21 | Ildong Pharmaceutical Co., Ltd. | Novel Acid Secretion Inhibitor and use thereof |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3285991A (en) | 1963-03-26 | 1966-11-15 | Union Carbide Corp | Polyepoxides cured with the reaction product of a dihydroxydiphenylsul-fone, an amine, and an aldehyde |
| US4847289A (en) | 1987-06-08 | 1989-07-11 | Merck & Co., Inc. | Thiophene sulfonamide antiglaucoma agents |
| MX9205392A (es) | 1991-10-29 | 1993-04-01 | Du Pont | Triazolcarbozamidas herbicidas y procedimiento para su obtencion. |
| KR100387157B1 (ko) | 1994-09-26 | 2003-09-29 | 시오노기세이야쿠가부시키가이샤 | 이미다졸유도체 |
| JPH0948778A (ja) | 1995-08-04 | 1997-02-18 | Sagami Chem Res Center | ２−置換−３−アルコキシ−５−（ピロール−２−イル）フラン誘導体 |
| DK0873123T3 (da) | 1995-11-06 | 2003-08-04 | Univ Pittsburgh | Inhibitorer af protein-isoprenyltransferaser |
| AU730224B2 (en) | 1996-12-23 | 2001-03-01 | Du Pont Pharmaceuticals Company | Nitrogen containing heteroaromatics as factor Xa inhibitors |
| WO1999042461A1 (en) | 1998-02-23 | 1999-08-26 | Warner-Lambert Company | Substituted quinoxaline derivatives as interleukin-8 receptor antagonists |
| JP4634144B2 (ja) | 2002-08-01 | 2011-02-16 | ニコックス エスエー | ニトロソ化プロトンポンプ阻害剤、組成物および使用方法 |
| ATE410161T1 (de) | 2003-05-02 | 2008-10-15 | Elan Pharm Inc | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen |
| ATE482933T1 (de) | 2003-05-26 | 2010-10-15 | Takeda Pharmaceutical | Sulfopyrrolderivate |
| CA2532800C (en) | 2003-07-23 | 2013-06-18 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
| KR101178747B1 (ko) | 2004-09-30 | 2012-09-03 | 다케다 야쿠힌 고교 가부시키가이샤 | 프로톤 펌프 저해제 |
| HRP20110473T1 (hr) | 2005-08-30 | 2011-07-31 | Takeda Pharmaceutical Company Limited | Supstituirani derivati 1-heterociklilsulfonil, 2-aminometil, 5-(hetero)-aril 1-h-pirola kao inhibitori kiselinske sekrecije |
| US7994205B2 (en) | 2006-03-31 | 2011-08-09 | Takeda Pharmaceutical Company Limited | Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors |
| US8933105B2 (en) * | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| JP2009077078A (ja) | 2007-09-19 | 2009-04-09 | Brother Ind Ltd | 位置検出システム |
| EP2190822B1 (en) | 2007-09-28 | 2014-12-31 | Takeda Pharmaceutical Company Limited | 5-membered heterocyclic compounds as proton pump inhibitors |
| KR101559597B1 (ko) | 2007-09-28 | 2015-10-12 | 다케다 야쿠힌 고교 가부시키가이샤 | ５―원 헤테로시클릭 화합물 |
| PE20091846A1 (es) | 2008-05-19 | 2009-12-16 | Plexxikon Inc | DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS |
| CN102099339A (zh) | 2008-07-18 | 2011-06-15 | 武田药品工业株式会社 | 苯并氮杂衍生物及其作为组胺h3拮抗剂的用途 |
-
2010
- 2010-03-25 CN CN201080023162.7A patent/CN102448953B/zh active Active
- 2010-03-25 BR BRPI1009090A patent/BRPI1009090A2/pt not_active IP Right Cessation
- 2010-03-25 EA EA201171168A patent/EA019853B1/ru not_active IP Right Cessation
- 2010-03-25 SG SG2011067808A patent/SG174476A1/en unknown
- 2010-03-25 WO PCT/JP2010/055257 patent/WO2010110378A1/ja not_active Ceased
- 2010-03-25 UA UAA201112488A patent/UA107457C2/uk unknown
- 2010-03-25 AU AU2010228220A patent/AU2010228220B2/en not_active Ceased
- 2010-03-25 MX MX2011009943A patent/MX2011009943A/es active IP Right Grant
- 2010-03-25 PE PE2011001696A patent/PE20120618A1/es not_active Application Discontinuation
- 2010-03-25 KR KR1020117024240A patent/KR101656906B1/ko active Active
- 2010-03-25 US US13/260,507 patent/US8895588B2/en active Active
- 2010-03-25 EP EP10756174.8A patent/EP2412713B1/en active Active
- 2010-03-25 NZ NZ595890A patent/NZ595890A/xx not_active IP Right Cessation
- 2010-03-25 CA CA2756086A patent/CA2756086A1/en not_active Abandoned
- 2010-03-25 GE GEAP201012426A patent/GEP20156222B/en unknown
- 2010-03-25 MA MA34275A patent/MA33214B1/fr unknown
- 2010-03-25 JP JP2011506117A patent/JP5552481B2/ja active Active
-
2011
- 2011-08-25 EC EC2011011419A patent/ECSP11011419A/es unknown
- 2011-09-19 IL IL215235A patent/IL215235A/en not_active IP Right Cessation
- 2011-09-21 TN TN2011000474A patent/TN2011000474A1/fr unknown
- 2011-09-23 DO DO2011000296A patent/DOP2011000296A/es unknown
- 2011-09-23 CL CL2011002351A patent/CL2011002351A1/es unknown
- 2011-10-11 ZA ZA2011/07435A patent/ZA201107435B/en unknown
- 2011-10-12 CR CR20110533A patent/CR20110533A/es unknown
- 2011-10-26 CO CO11144548A patent/CO6460700A2/es active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012002349A2 (pt) | composto,e, uso do mesmo | |
| BRPI1012533A2 (pt) | composto de piradazinona e uso do mesmo | |
| SMT201600258B (it) | Composto indolico e suo uso farmaceutico | |
| BRPI1008498A2 (pt) | Composto, prodroga do composto, medicamento, e, uso de um composto. | |
| BRPI1007494A2 (pt) | composto e uso do mesmo | |
| PL2452709T3 (pl) | Kaniula | |
| BR112013016772A2 (pt) | composto, uso do composto, composição farmacêutica, oligonucleotídeo e conjugado | |
| BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
| BRPI0821668A2 (pt) | Uso | |
| BRPI0920521A2 (pt) | combinação farmacêutica | |
| BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
| DK2114993T3 (da) | Vaccine | |
| EP2296593A4 (en) | MEDICAL HEAD COVER | |
| BR112013011448A2 (pt) | composto, composição farnmacêutica, e, uso do composto | |
| BRPI0909770A2 (pt) | Vacina, e, kit | |
| BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
| FI20086250A0 (fi) | Sieniendoglukanaasit, niiden valmistus ja käyttö | |
| IT1403847B1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| DK2125048T3 (da) | Præparat | |
| BRPI1006996A2 (pt) | composição, método e uso | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
| BRPI1011036A2 (pt) | uso | |
| EP2197448A4 (en) | dosing schedule | |
| BR112013013551A2 (pt) | composto e uso médico do mesmo | |
| BR112013012175A2 (pt) | combinação, coadministração, uso e método |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |